These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38048020)

  • 1. Meningococcal Disease in the Post-COVID-19 Era: A Time to Prepare.
    Bloom DE; Bonanni P; Martinón-Torres F; Richmond PC; Safadi MAP; Salisbury DM; Charos A; Schley K; Findlow J; Balmer P
    Infect Dis Ther; 2023 Dec; 12(12):2649-2663. PubMed ID: 38048020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing patterns of invasive meningococcal disease and future immunization strategies.
    Taha MK; Bekkat-Berkani R; Abitbol V
    Hum Vaccin Immunother; 2023 Dec; 19(1):2186111. PubMed ID: 37017273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations.
    Martinón-Torres F; Taha MK; Knuf M; Abbing-Karahagopian V; Pellegrini M; Bekkat-Berkani R; Abitbol V
    Pathog Glob Health; 2022 Mar; 116(2):85-98. PubMed ID: 34569453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The important lessons lurking in the history of meningococcal epidemiology.
    Borrow R; Findlow J
    Expert Rev Vaccines; 2024; 23(1):445-462. PubMed ID: 38517733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.
    Parikh SR; Campbell H; Bettinger JA; Harrison LH; Marshall HS; Martinon-Torres F; Safadi MA; Shao Z; Zhu B; von Gottberg A; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Oct; 81(4):483-498. PubMed ID: 32504737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine.
    Ruiz Garcia Y; Abitbol V; Pellegrini M; Bekkat-Berkani R; Soumahoro L
    Infect Dis Ther; 2022 Apr; 11(2):639-655. PubMed ID: 34591258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
    Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G
    Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls.
    Prunas O; Weinberger DM; Medini D; Tizzoni M; Argante L
    Am J Epidemiol; 2022 Mar; 191(4):724-734. PubMed ID: 34753175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.
    Taha MK; Martinon-Torres F; Köllges R; Bonanni P; Safadi MAP; Booy R; Smith V; Garcia S; Bekkat-Berkani R; Abitbol V
    Expert Rev Vaccines; 2022 May; 21(5):659-674. PubMed ID: 35271781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.
    Booy R; Gentile A; Nissen M; Whelan J; Abitbol V
    Hum Vaccin Immunother; 2019; 15(2):470-480. PubMed ID: 30296197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic's influence on parents' attitudes and behaviors toward meningococcal vaccination.
    Tan LLJ; Safadi MAP; Horn M; Regojo Balboa C; Moya E; Schanbaum J; Pimenta P; Lambert E; Soumahoro L; Sohn WY; Bruce T; Ruiz García Y
    Hum Vaccin Immunother; 2023 Dec; 19(1):2179840. PubMed ID: 36883777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
    Si S; Zomer E; Fletcher S; Lee J; Liew D
    Vaccine; 2019 Aug; 37(35):5009-5015. PubMed ID: 31301916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal infections among refugees and immigrants: silent threats of past, present and future.
    Dinleyici EC; Borrow R
    Hum Vaccin Immunother; 2020 Nov; 16(11):2781-2786. PubMed ID: 32347773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies.
    Thisyakorn U; Carlos J; Chotpitayasunondh T; Dien TM; Gonzales MLAM; Huong NTL; Ismail Z; Nordin MM; Ong-Lim ALT; Tantawichien T; Terumalay SD; Vu TD; Cintra O; Oladehin O
    Hum Vaccin Immunother; 2022 Nov; 18(6):2110759. PubMed ID: 36084311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa.
    Taha MK; Presa J; Serra L
    Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines.
    Pelton SI
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S3-S11. PubMed ID: 27449148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Sequelae of Invasive Meningococcal Disease in the United States.
    Marshall GS; McCormick ZL; Johns JS; Verduzco-Gutierrez M; Herrera-Restrepo O; Harrison LH
    Infect Dis Ther; 2024 Nov; 13(11):2213-2220. PubMed ID: 39269567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.
    Bousema JC; Ruitenberg J
    Int J Health Policy Manag; 2015 Sep; 4(11):757-61. PubMed ID: 26673336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.